LIGAND PHARMACEUTICALS

LGNDNASDAQ

🏆 #1152 by market capEarnings Nov 5US Equity

$310.36▼ $3.69 (−1.19%)

🌙 After hours$310.36▲ 0.00%Regular close · extended-hours price shown

🔔

Track LGND

Get earnings, price moves & breaking news on Telegram

Track

24h▼ 1.2%

7d▲ 3.6%

14d▲ 12.7%

30d▲ 9.2%

ytd▲ 64.1%

1y▲ 75.1%

🏦Market Cap

$6.22B

Small Cap

📈Revenue Growth (YoY)

+54.9%

High Growth

📊Gross Margin

95.4%

High

💵FCF Margin

46.2%

Strong

⚖️P/S Ratio

20.6x

Expensive

Otter Score

Fair

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

2.37

Expected

2.01

beat

+17.90%

YoY +48.10%

Revenue

Actual

$63.69M

Expected

$61.30M

beat

+3.90%

YoY +33.70%

Consensus estimates

Recent quarters

Q3 2026

2.37

beat

Q2 2026

1.63

miss

Q1 2026

2.02

beat

Q4 2025

3.09

beat